Urethritis is an inflammation of the urethra that is commonly caused by sexually transmitted pathogens like Neisseria gonorrhoeae and Chlamydia trachomatis. It presents with symptoms like burning during urination and discharge from the penis. Diagnosis involves examination for discharge and testing first-voided urine or urethral swabs. Treatment involves antibiotics like azithromycin or ceftriaxone to cover gonococcal and non-gonococcal causes. Complications are rare but may include strictures or spread to the epididymis or prostate.
Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control.
The urethra's main job in males and females is to pass urine outside the body. This thin tube also has an important role in ejaculation for men. When a scar from swelling, injury or infection blocks or slows the flow of urine in this tube, it is called a urethral stricture. Some people feel pain with a urethral stricture.
Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control.
The urethra's main job in males and females is to pass urine outside the body. This thin tube also has an important role in ejaculation for men. When a scar from swelling, injury or infection blocks or slows the flow of urine in this tube, it is called a urethral stricture. Some people feel pain with a urethral stricture.
Pyelonephritis
It is the inflammation of the kidney & upper urinary tract that usually results from the bacterial infection of the bladder.
Pyelonephritis can be classified in several different catagories:
-acute pyelonephritis
-chronic pyelonephritis
-xanthogranulomatous pyelonephritis
Benign prostatic hyperplasia is an enlargement of the prostate gland resulting from an increase in the number of epithelial cells and stromal tissue and developing upward into the bladder and obstructing the outflow of urine.
In this presentation I have shown the etiology, clinical features and treatment for both Phimosis & Paraphimosis. I have also showed various methods of circumcision for both infants and adults.
Pyelonephritis
It is the inflammation of the kidney & upper urinary tract that usually results from the bacterial infection of the bladder.
Pyelonephritis can be classified in several different catagories:
-acute pyelonephritis
-chronic pyelonephritis
-xanthogranulomatous pyelonephritis
Benign prostatic hyperplasia is an enlargement of the prostate gland resulting from an increase in the number of epithelial cells and stromal tissue and developing upward into the bladder and obstructing the outflow of urine.
In this presentation I have shown the etiology, clinical features and treatment for both Phimosis & Paraphimosis. I have also showed various methods of circumcision for both infants and adults.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
3. Urethritis
• inflammation of urethra which is multifactorial condition and
characterised bydysuria with/without urethral discharge or may
be asymptomatic.
4. Epidemiology
• Urethritis usually resolves without complication even if untreated, yet it
can result in urethral stricture, stenosis, or abscess formation in rare
cases.
• Recurrent urethritis may occur from reinfection, therapeutic
failure or "venereophobia"
• Urethritis is predominantly a disease of adolescent and adult men. The
prevalence is greatest in men younger than 25 years.
• Worldwide, approximately 62 million new cases of N. gonorrhoeae and 89
million new cases of nongonococcal urethritis are reported each year.
6. Types
• 1.Gonococcal Urethritis - pathogen is gonococci
• 2. Non gonococcal Urethritis –identified pathogen other than
gonococci
• 3.Non specific Urethritis- unidentified pathogen.
7. • Urethritis is an inflammatory condition that can be infectious or post
traumatic in nature.
• Infectious causes of urethritis are typically sexually transmitted and
categorized as either gonococcal urethritis (ie, due to infections with
Neisseria gonorrhoeae) or
• NGU ………ie, due to infections with …..
• Chlamydia trachomatis,
• Ureaplasma urealyticum,
• Mycoplasma hominis,
• Mycoplasma genitalium, or
• Trichomonas vaginalis).
8. • Rare infectious causes of Urethritis include ……………..
• lymphogranuloma venereum,
• herpes simplex virus types 1 and 2,
• adenovirus,
• syphilis,
• mycobacterial infection, and bacterial infections that are
typically associated with cystitis (usually gram-negative rods)
in the presence of urethral stricture.
9. • Other rare but reported causes of urethritis include…………
• viral
• streptococcal
• anaerobic, and
• meningococcal infections
10. • Post traumatic urethritis can occur in 2%-20% of patients practicing intermittent
catheterization and following instrumentation or foreign body insertion.
• Urethritis is 10 times more likely to occur with latex catheters than with silicone
catheters.
• Urethritis may be associated with other infectious syndromes, such as the
following:
• Epididymitis
• Orchitis
• Prostatitis
• Proctitis
• Reactive arthritis
• Iritis
• Pneumonia
• Otitis media
• Urinary tract infection
11.
12. • Burning on urination
• Frequent urination with only small
amounts of urine passed on each
occasion
• Anal or oral infections
• Urgent need to urinate
• Bloody discharge from the penis
• Blood in the urine
• Yellowish discharge from the urethra
• Itching or irritation around the
opening of the penis
• Lower abdominal pain
• Painful sexual intercourse in women
13. • Examination patients with urethritis includes the following:
• Most patients with urethritis do not appear ill and do not present with
signs of sepsis.
• The primary focus of the examination is on the genitalia.
• Penis: Examine for skin lesions that may indicate other STDs (eg,
condyloma acuminatum, herpes simplex, syphilis); in uncircumcised men,
retract the foreskin to assess for lesions and exudate
• Urethra: Examine lumen of the distal urethral meatus for lesions, stricture,
or obvious urethral discharge; palpate along urethra for areas of
fluctuance, tenderness, or warmth suggestive of abscess or for firmness
suggesting foreign body
14. • Testes: Examine for evidence of mass or inflammation; palpate
the spermatic cord, looking for swelling, tenderness, or warmth
suggestive of orchitis or epididymitis
• Lymphatics: Check for inguinal adenopathy
• Prostate: Palpate for tenderness or bogginess suggestive of
prostatitis
• Rectal: During the digital rectal examination, note any perianal
lesions
15. • Urethritis can be diagnosed based on the presence of one or more of the
following:
• A mucopurulent or purulent urethral discharge
• Urethral smear that demonstrates at least 5 leukocytes per oil immersion field
on microscopy
• First-voided urine specimen that demonstrates leukocyte esterase on dipstick
test or at least 10 WBCs/hpf on microscopy
• All patients with urethritis should be tested for Neisseria gonorrhoeae and
C trachomatis.
16. Laboratory studies may include the following:
• Gram stain
• Endourethral and/or endocervical culture for N gonorrhoeae and C trachomatis
• Urinalysis: Not useful test in urethritis, except to help exclude cystitis or
pyelonephritis
• Nucleic acid–based tests: For C trachomatis and N gonorrhoeae (urine
specimens) and other Chlamydia species (endourethral samples)
• Nucleic acid amplification tests (eg, PCR for N gonorrhoeae, Chlamydia species)
• KOH preparation: to evaluate for fungal organisms
• Wet mount preparation: To detect the movement/presence of Trichomonas
• STD testing for syphilis serology (VDRL) and HIV serology
• Nasopharyngeal and/or rectal swabs: For gonorrhea screening in men who have
sexual intercourse with men.
17. •
• Imaging studies, specifically retrograde urethrography, are unnecessary in
patients with urethritis, except in cases of trauma or possible foreign body
insertion.
• Procedures :
• Patients with urethritis may undergo the following procedures:
• Catherization: In cases of urethral trauma; to avoid urinary retention and
tamponade urethral bleeding
Cystoscopy: In cases when catherization is not possible, for placement of a
catheter; to remove foreign body or stone in the urethra
• Dilation of urethral strictures with filiforms and followers
• Placement of suprapubic tube: In severe cases of urethral trauma that prevent
placement of urethral catheters or in the absence of adequate facilities for
emergent cystoscopy; temporizing measure to divert urine and relieve patient
discomfort
18. • Symptoms of urethritis spontaneously resolve over time, regardless of treatment. Administer
antibiotics that cover both GU and NGU. Regardless of symptoms, administer antibiotics to
the following individuals:
• Patients with positive Gram stain or culture results :
• All sexual partners of the above patients
• Patients with negative Gram stain results and a history consistent with urethritis who are not
likely to return for follow-up and/or are likely to continue transmitting infection
• Antibiotics used in the treatment of urethritis include the following:
• Azithromycin
• Ceftriaxone
• Cefixime
• Ciprofloxacin
• Ofloxacin
• Doxycycline
• Moxifloxacin
19. • Complications, such as stricture, stenosis, or abscess formation, are quite rare. Concomitant
epididymitis or prostatitis is not uncommon.
• PID and tubo-ovarian abscess are known complications of urethritis in females that may
predispose to infertility. In addition, increasing evidence shows that genital chlamydial
infection in males may predispose to infertility. In addition, both Chlamydia and U urealyticum
can impair sperm and adversely affect semen parameters.
• All patients with uncomplicated urethritis spontaneously recover with or without treatment.
• Prevention: Educate at-risk patients on how to prevent disease recurrence.
• Educate patients on risks of other sexually-transmitted infections, including HIV.
• Try to find asymptomatic patients and symptomatic patients who are unlikely to seek
treatment.
• Early diagnosis and treatment of infected individuals is essential.
• Evaluate and treat sexual partners of known infected persons.